Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine Sustained-Release Capsules Bioequivalence Study (Fed)
NCT04229602Phase 1Unknown
- Sponsor
- Beijing Tongren Hospital
- Start
- Jan 2020
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of venlafaxine in major depressive disorder (MDD), generalized anxiety disorder (GAD), Social Anxiety Disorder (SAD) and 1 more, sponsored by Beijing Tongren Hospital. Status: unknown.
02
Drugs
venlafaxine
03
Conditions
major depressive disorder (MDD)generalized anxiety disorder (GAD)Social Anxiety Disorder (SAD)panic disorder
Beyond the preview
Go deeper on NCT04229602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04229602.